Approval · Notice of Compliance 16167 · 2014
LASIX: Notice of Compliance 16167
Issued October 10, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16167
- Date
- October 10, 2014
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation
- Therapeutic class
- Diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LASIX | Not yet assigned | — |
Medicinal ingredients
- FUROSEMIDE 500 MG per TAB